Leidos Holdings Stock Price, News & Analysis

Leidos (NYSE: LDOS) has secured a prime contract with the Transportation Security Authority (TSA) valued at $470.7 million to assist in deploying Transportation Screening Equipment (TSE) across U.S. federalized airports. This indefinite delivery/indefinite quantity contract will enable Leidos to conduct surveys, provide design support, and oversee the installation, relocation, and removal of screening equipment. Leidos has previously supported TSA for over 12 years, enhancing operational efficiency and safety at airports and special events.

Leidos has been awarded a prime contract by the CDC to provide bioinformatics and scientific computing support services, valued at over $13 million over five years. This contract enhances CDC's capacity in handling large datasets and high-performance computing for health-related research. The work will be primarily based in Atlanta, Georgia.

Liz Porter, Leidos Health Group president, emphasized the importance of this collaboration in investigating infectious pathogens and advancing public health.

Leidos Holdings has extended its offers for the exchange of various notes totaling $2.25 billion, including 2.950% Notes due 2023 and others, to expire on June 21, 2021. This extension is due to the announcement that June 18 will be a federal holiday. As of June 17, 2021, the company reported significant tendering amounts: 59.7% for the 2023 Notes and over 85% for the 2025 Notes. Other notes tendered include 70.1% for the 2030 Notes and 81.1% for the 2031 Notes. Citibank is the exchange agent for the offers.

Leidos (NYSE: LDOS) has secured a prime contract from the U.S. Army for commercial health services to military reserve forces, valued at $999 million if all options are exercised. This contract spans a one-year base period, with four additional one-year options. Leidos will collaborate with the Defense Health Agency to meet health requirements for service members before, during, and after deployment. Liz Porter, the Health Group president, emphasized the commitment to serving military reservists, while CEO Larry Schaefer stressed the dedication to innovation and customer service in healthcare.

Leidos (NYSE: LDOS) announced its advancement into the final phase of the USSOCOM's Armed Overwatch aircraft prototype program alongside Paramount USA and Vertex. The team has been awarded $19.3 million for prototype demonstrations, focusing on the Bronco II aircraft, which boasts mission flexibility through its Interchangeable Multi-Mission System Bay. Leidos' team aims to showcase the Bronco II's capabilities for ISR, SCAR, and CAS missions. The program is critical for future military operational requirements, showcasing Leidos' ongoing commitment to innovative defense solutions.

Leidos (NYSE: LDOS) announced its advancement to Phase III of the U.S. Special Operations Command's Armed Overwatch aircraft prototype program with its Bronco II aircraft. Partnering with Paramount Group USA and Vertex Aerospace, the Leidos team will demonstrate the aircraft's capabilities in a fly-off. Bronco II is designed for rapid deployment and modularity, allowing for diverse mission configurations. This contract signifies Leidos' commitment to providing advanced military solutions and supporting national defense.

Leidos (NYSE: LDOS), a leader in information technology and engineering, will participate in the Stifel 2021 Virtual Cross Sector Insight Conference on June 10, 2021, at 4:40 p.m. ET. Chris Cage, Corporate Controller and incoming CFO, will engage in a fireside chat during the event. Interested investors can access the live audio webcast on the Leidos Investor Relations website, with a replay available for 90 days post-event. Leidos reported revenues of approximately $12.30 billion for the fiscal year ending January 1, 2021, emphasizing its role in tackling complex challenges across various sectors.

Leidos (NYSE: LDOS) has secured a prime contract worth up to $110 million from the FBI to provide fitness for duty medical exam services. Awarded by the FBI's Human Resources Division, the contract includes a base period of 12 months with four potential 12-month extensions. QTC Medical Services, a subsidiary of Leidos, will offer various occupational health services, building on its existing relationship with the FBI since 2012. This contract expands QTC's role in supporting FBI personnel with comprehensive medical examinations and related services.

Leidos (NYSE: LDOS), a leader in technology and science solutions, will participate in the Bernstein 37th Annual Strategic Decisions Conference on June 2, 2021, at 1:30 p.m. ET. CEO Roger Krone will engage in a Q&A session during the event. The conference will be accessible via a live audio webcast on the Leidos Investor Relations website. Following the event, a replay will be available for one year. Leidos, headquartered in Reston, VA, reported annual revenues of approximately $12.30 billion in the fiscal year ended January 1, 2021.